Showing results (311-320 of 355) with videos related to
Sort By:
Pageof 36
British Journal of Cancer|March 1, 1990
A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials CommitteeJ Carmichael, B M Cantwell, K A Mannix, et al.Critical Care Medicine|August 2, 2000
A phase I study of oxidized raffinose cross-linked human hemoglobinF J Carmichael, A C Ali, J A Campbell, et al.Journal of the National Cancer Institute|July 6, 2000
Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancerM Ranson, N Davidson, M Nicolson, et al.European Journal of Respiratory Diseases|April 1, 1983
Bromocriptine in severe adult asthma--a negative reportS P Hanley, N J Brennan, T C Stokes, et al.European Journal of Cancer & Clinical Oncology|July 1, 1985
cis-Platinum and vindesine in combination in the treatment of non-small cell lung cancerJ Carmichael, A Gregor, M A Cornbleet, et al.Ambio|January 30, 2007
General effects of climate change on Arctic fishes and fish populationsJames D Reist, Frederick J Wrona, Terry D Prowse, et al.Carcinogenesis|June 1, 1992
Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibilityC R Wolf, C A Smith, A C Gough, et al.Human Molecular Genetics|September 5, 2001
Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's diseaseA Wyttenbach, J Swartz, H Kita, et al.Ambio|January 30, 2007
Effects of climate change and UV radiation on fisheries for arctic freshwater and anadromous speciesJames D Reist, Frederick J Wrona, Terry D Prowse, et al.Cancer Chemotherapy and Pharmacology|October 11, 2001
Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liverR A Sharma, M M Eatock, C J Twelves, et al.Pageof 36